Monteris Medical获得2800万美元增长股权，以加速微创神经外科领域的收入和创新-动脉网

Monteris Medical Secures $28 Million in Growth Equity to Accelerate Revenue and Innovation in Minimally Invasive Neurosurgery

PR Newswire 等信源发布 2026-03-12 21:25



可切换为仅中文







MINNETONKA, Minn.

明尼通卡，明尼苏达州

，

March 12, 2026

2026年3月12日

/PRNewswire/ --

Monteris Medical

蒙特里斯医疗

, a private company leading the field in minimally invasive neurosurgery with its NeuroBlate® System for magnetic resonance-guided laser interstitial thermal therapy (LITT), announced today that it has closed $28 million in Series E equity financing. The equity capital will support the company's technology innovation program and other growth initiatives.

，一家在微创神经外科领域处于领先地位的私人公司，以其用于磁共振引导激光间质热疗（LITT）的NeuroBlate®系统而闻名，今天宣布已完成2800万美元的E轮融资。这笔股权资本将支持公司的技术创新计划及其他增长举措。

Monteris also announced that it has refinanced its current debt and established a new $35 million credit facility with Trinity Capital..

Monteris 还宣布，其已经对现有债务进行了再融资，并与 Trinity Capital 建立了新的 3500 万美元信贷额度。

Proceeds from the equity financing will be used to expand the company's U.S. commercial footprint and accelerate Monteris' other growth initiatives in technology development, clinical research and geographic expansion.

股权融资所得将用于扩大公司在美国的商业版图，并加速Monteris在技术开发、临床研究和地域扩张方面的其他增长计划。

The equity round included Monteris' current lead investors, InnovaHealth Partners and Birchview Capital, LP, along with participation from several new investors including OSF Ventures, the investment arm of Peoria, Ill.-based OSF HealthCare, and the Colorado University Healthcare Innovation Fund. Both are healthcare system venture funds affiliated with institutions that offer the Monteris NeuroBlate technology to their patients.

这轮股权融资包括蒙特瑞斯当前的主要投资者InnovaHealth Partners和Birchview Capital，LP，以及几家新投资者的参与，其中包括OSF Ventures（伊利诺伊州皮奥里亚市OSF HealthCare的投资部门）和科罗拉多大学医疗创新基金。这两家都是与向患者提供Monteris NeuroBlate技术的机构相关的医疗系统风险基金。

The company's previous credit facility partner, Madryn Asset Management, LP, is also a major participant in the equity round..

公司之前的信贷机构合作伙伴Madryn资产管理公司也参与了这轮股权融资。

'OSF Ventures looks to invest in organizations that bring meaningful innovation to the clinicians and patients we serve,' said Mayank Taneja, vice president, Venture Investments of OSF Ventures. 'Our clinicians have firsthand experience using Monteris' technology in practice, and we're excited to support a company whose evidence-based solutions make a significant impact in the field of minimally invasive neurosurgery.

“OSF Ventures希望投资那些为我们的临床医生和患者带来有意义创新的机构，”OSF Ventures风险投资副总裁Mayank Taneja表示，“我们的临床医生在实践中亲身体验过Monteris的技术，我们非常高兴支持一家通过基于证据的解决方案在微创神经外科领域产生重大影响的公司。”

Moreover, our vision of improving the lives of those we serve aligns with Monteris' mission to deliver hope and healing to the patients, families and care teams who rely on innovations like this.'.

此外，我们改善服务对象生活的愿景与Monteris的使命一致，即为依赖此类创新的患者、家庭和护理团队带来希望和治愈。

Monteris' strong operational results, combined with its near-term pathway to profitability and positive cash flow, allowed the company to retire its prior credit facility with Madryn Asset Management and secure a $35 million credit facility with Trinity Capital, resulting in longer-term financial flexibility and an improved cost of debt..

蒙特里斯强劲的运营结果，加上其短期内实现盈利和正现金流的路径，使公司能够终止与马德林资产管理公司的先前信贷安排，并获得 Trinity Capital 提供的 3500 万美元信贷额度，从而带来更长期的财务灵活性和降低债务成本。

'Monteris Medical has established itself as a category leader in minimally invasive neurosurgery, with a technology platform that is supported by clinical evidence and plays an important role in advancing neurosurgical care,' said Rob Lake, senior managing director of Life Sciences at Trinity Capital.

“Monteris Medical 已经确立了其在微创神经外科领域的领先地位，其技术平台得到了临床证据的支持，并在推动神经外科护理方面发挥了重要作用，”Trinity Capital 生命科学高级董事总经理 Rob Lake 表示。

'We look forward to being a long-term financial partner as Monteris enters its next stage of growth.'.

“我们期待成为Monteris进入下一个增长阶段的长期财务合作伙伴。”

Mayank Taneja and Alex Marcantonio, managing director of Madryn Asset Management, have been added to Monteris' board of directors.

马德林资产管理公司董事总经理马扬克·塔内贾和亚历克斯·马坎托尼奥已加入蒙特里斯董事会。

'Monteris continues to build momentum as the preferred partner for neurosurgeons seeking minimally invasive options for patients with brain tumors and drug-resistant epilepsy,' said Richard Emmitt, Monteris' board chair. 'The support from both new and existing investors reflects strong confidence in NeuroBlate technology, Monteris' strategy and the growing clinical demand for the NeuroBlate solution.'.

“Monteris 作为神经外科医生寻求脑肿瘤和抗药性癫痫患者的微创治疗方案的首选合作伙伴，持续增强其发展势头，”Monteris 董事会主席 Richard Emmitt 表示。“来自新老投资者的支持反映了对 NeuroBlate 技术、Monteris 的战略以及市场对 NeuroBlate 解决方案日益增长的临床需求的强烈信心。”

About Monteris and the NeuroBlate

关于Monteris和NeuroBlate

System

系统

Monteris Medical develops and markets innovative MR‑guided laser ablation systems that enable minimally invasive, robotically controlled brain surgery - often referred to as laser ablation, LITT (laser interstitial thermal therapy) or SLA (stereotactic laser ablation). The company's NeuroBlate System, used in nearly 130 health systems across North America, is designed for adults and children aged two and older and uses laser technology to precisely destroy abnormal brain tissue, including certain brain tumors and specific areas of the brain that cause seizures due to epilepsy.

Monteris Medical 开发并销售创新的磁共振引导激光消融系统，该系统能够实现微创、机器人控制的脑部手术——通常被称为激光消融、LITT（激光间质热疗）或 SLA（立体定向激光消融）。该公司旗下的 NeuroBlate 系统已被北美近 130 家医疗系统使用，适用于两岁及以上的儿童和成人，利用激光技术精准摧毁异常脑组织，包括某些脑肿瘤和因癫痫引发癫痫发作的特定脑区。

NeuroBlate is the only LITT platform with a robotic interface that supports the targeted, safe delivery of laser energy and is supported by published prospective clinical data. Multicenter studies on NeuroBlate show that patients typically experience short hospital stays, low rates of complications, improved quality of life and outcomes comparable to open surgical resection.

NeuroBlate 是唯一一个拥有机器人界面的LITT平台，该平台支持靶向、安全地传递激光能量，并有已发表的前瞻性临床数据支持。关于NeuroBlate 的多中心研究表明，患者通常住院时间短，并发症发生率低，生活质量得到改善，疗效与开放手术切除相当。

For more information, visit .

欲了解更多信息，请访问。

monteris.com

蒙特里斯.com

。

Investor Contact:

投资者联系方式：

Monteris Medical

蒙特里斯医疗

Doug Pahr – Chief Financial Officer

道格·帕尔 – 首席财务官